Bromide

Bromide

SCHEMBL6524161

Br.N=c1ccc(Br)cn1CC(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D known ✓ P25100 1/20 0.36
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
CSNK2A2 P19784 1/20 0.36
CSNK2A1 P68400 1/20 0.36
FPR2 P25090 4/20 0.35
KMT2A Q03164 5/20 0.35
HTT P42858 2/20 0.35
RAB9A P51151 3/20 0.35
RECQL P46063 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 1/20 0.35
CASP6 P55212 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
STAT3 P40763 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3409817 0.98 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EPOLBADRA1D
SCHEMBL4893880 0.78 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EPOLBCSNK2A2
SCHEMBL9517884 0.76 PTGDR2 (0.41) ALDH1A1MAPTKDM4EPOLBADRA1D
SCHEMBL22519187 0.72 KDM4E (0.43) ALDH1A1MAPTKDM4EPOLBRAB9A
SCHEMBL23639739 0.70
SCHEMBL3719707 0.68 KDM4E (0.53) ALDH1A1MAPTKDM4EKMT2AHTT
SCHEMBL24163129 0.67 CSNK2A2 (0.38) ALDH1A1MAPTKDM4EPOLBADRA1D
SCHEMBL13269646 0.66 LIPG (0.41) ALDH1A1MAPTKDM4EPOLB
SCHEMBL11160938 0.64 CSNK2A2 (0.42) ALDH1A1MAPTKDM4EPOLBCSNK2A2
SCHEMBL18663431 0.64 MEN1 (0.35) ALDH1A1KDM4EADRA1DKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123288-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (US) 2013-05-16 US disclosed
US-8338451-B2 Polysubstituted derivatives of 2-heteroaryl-6-phenylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI (FR) 2012-12-25 US disclosed
US-20110065727-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123288-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN ADRA1D 838/4885ALDH1A1 280/4885MAPT 2743/4885
US-20110065727-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN ADRA1D 838/4885ALDH1A1 280/4885MAPT 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.